Intellectual Property India Publishes Patent Application for Translation Enhancing Nucleic Acid Compounds: Aso Coupled Translation - Upregulation 1 (act-Up1) And Uses Thereof

MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617084863 A) filed by Arnatar Therapeutics, Inc on July 10, 2026, for Translation Enhancing Nucleic Acid Compounds: Aso Coupled Translation - Upregulation 1 (act-Up1) And Uses Thereof.

Inventors include Liang, Xuehai; and Zhang, Lingdi.

The application for the patent was published on September 04, 2026, under issue no. 36/2026.

Abstract: Disclosed herein are methods and compounds for enhancing gene expression by ACT-UP1 compounds. Such methods and compounds are useful for increasing expression of certain genes, many of which are associated, with a variety of diseases and disorders.

Disclaimer: Curated by HT Syndication.